Загрузка...

Endocrine therapy use among elderly hormone receptor-positive breast cancer patients enrolled in Medicare Part D

BACKGROUND: Clinical guidelines recommend that women with hormone-receptor positive breast cancer receive endocrine therapy (selective estrogen receptor modulators [SERMs] or aromatase inhibitors [AIs]) for five years following diagnosis. OBJECTIVE: To examine utilization and adherence to therapy fo...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Riley, Gerald F., Warren, Joan L., Harlan, Linda C., Blackwell, Steven A.
Формат: Artigo
Язык:Inglês
Опубликовано: Centers for Medicare & Medicaid Services 2011
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4010443/
https://ncbi.nlm.nih.gov/pubmed/22340780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5600/mmrr.001.04.a04
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!